Ocular adverse events associated with immune checkpoint inhibitors, a scoping review
Abstract Introduction Immune checkpoint inhibitors (ICIs) have become an important part of the treatment of multiple cancers, especially for advanced melanoma and non-small cell lung cancer. Some tumors are capable of escaping immunosurveillance by stimulating checkpoints on T-cells. ICIs prevent ac...
Main Authors: | A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels, S. Aspeslagh |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-02-01
|
Series: | Journal of Ophthalmic Inflammation and Infection |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12348-022-00321-2 |
Similar Items
-
Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature
by: Pauline Casselman, et al.
Published: (2023-04-01) -
Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
by: Sotiria Stavropoulou De Lorenzo, et al.
Published: (2024-06-01) -
Hypothesis for the development of immune-related adverse events in immune checkpoint inhibitors therapy
by: Rashida Orlova, et al.
Published: (2022-01-01) -
Managing Select Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
by: Parneet K. Cheema, et al.
Published: (2024-10-01) -
Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
by: Lingli Luo, et al.
Published: (2023-04-01)